Scientific article
English

Caspofungin in the treatment of oropharyngeal candidiasis

Published in

International journal of clinical practice, vol. 57, no. 2, p. 143-144

Publication date

2003

Abstract

A patient with AIDS developed oropharyngeal candidiasis. Candida albicans and C. glabrata were isolated from the patient and found to be resistant to fluconazole and itraconazole in vitro. Voriconazole therapy was initiated, but discontinued when the C. albicans strain isolated from the patient was found to be resistant to it. The patient failed to respond to subsequent therapy with a combination of amphotericin B and 5-flucytosine. Therapy with caspofungin was then initiated (70 mg loading dose, followed by 50 mg/day). The patient responded favourably to caspofungin, with complete resolution of signs and symptoms.

Keywords

  • AIDS-Related Opportunistic Infections/ drug therapy
  • Anti-Bacterial Agents/ therapeutic use
  • Antifungal Agents/ therapeutic use
  • Candidiasis/ drug therapy
  • Candidiasis, Oral/ drug therapy
  • Drug Resistance, Fungal
  • Echinocandins
  • Humans
  • Male
  • Middle Aged
  • Peptides
  • Peptides, Cyclic
  • Pharyngeal Diseases/ drug therapy
  • Treatment Outcome

Citation (ISO format)

GARBINO, Jorge et al. Caspofungin in the treatment of oropharyngeal candidiasis. In: International journal of clinical practice, 2003, vol. 57, n° 2, p. 143–144.

Identifiers

Journal ISSN

1368-5031
604views
0downloads

Technical informations

Creation

12/07/2010 14:36:49

First validation

12/07/2010 14:36:49

Update

14/03/2023 15:54:19

Status update

14/03/2023 15:54:19

Last indexation

29/10/2024 16:05:01
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated